PHILLIP A. SHARP - 15 Aug 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Issuer symbol
ALNY
Transactions as of
15 Aug 2022
Net transactions value
-$6,623,670
Form type
4
Filing time
17 Aug 2022, 16:07:02 UTC
Previous filing
02 Jun 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $902,700 +30,000 $30.09* 30,000 15 Aug 2022 Direct F1
transaction ALNY Common Stock Options Exercise $234,366 +3,670 +12% $63.86 33,670 15 Aug 2022 Direct F1
transaction ALNY Common Stock Sale $22,164 -98 -0.29% $226.16 33,572 15 Aug 2022 Direct F1
transaction ALNY Common Stock Sale $278,106 -1,218 -3.6% $228.33 32,354 15 Aug 2022 Direct F1, F2
transaction ALNY Common Stock Sale $2,667,188 -11,600 -36% $229.93 20,754 15 Aug 2022 Direct F1, F3
transaction ALNY Common Stock Sale $3,734,272 -16,186 -78% $230.71 4,568 15 Aug 2022 Direct F1, F4
transaction ALNY Common Stock Sale $892,547 -3,853 -84% $231.65 715 15 Aug 2022 Direct F1, F5
transaction ALNY Common Stock Sale $166,459 -715 -100% $232.81 0 15 Aug 2022 Direct F1, F6
holding ALNY Common Stock 266,899 15 Aug 2022 by Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -3,670 -100% $0.000000* 0 15 Aug 2022 Common Stock 3,670 $63.86 Direct F1, F8
transaction ALNY Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 15 Aug 2022 Common Stock 30,000 $30.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022.
F2 Sale prices ranged from $228.00 to $228.80.
F3 Sale prices ranged from $229.29 to $230.29.
F4 Sale prices ranged from $230.30 to $231.30.
F5 Sale prices ranged from $231.31 to $232.26.
F6 Sale prices ranged from $232.53 to $233.16.
F7 Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
F8 The stock option was fully vested as of 12/31/14.